Barinthus Biotherapeutics Barinthus Biotherapeutics (formerly known as Vaccitech) is a T-cell immunotherapy company developing products to treat and prevent cancer and infectious diseases. | ||
Founding Date | Founding Date 2008 | Founding Date 2016 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ Bryan, US | Locations Oxford, GB HQ |
Employees | Employees 1630% decrease | Employees 33 |
Valuation ($) | Valuation ($) 26.2 m | Valuation ($) 57.2 m |
Financial | ||
Revenue (est.) | Revenue (est.) $400k (FY, 2025) | Revenue (est.) N/A |
Funding | ||
Total funding raised | Total funding raised $ 9.3m | Total funding raised $ 195.1m |
Barinthus Biotherapeutics (formerly known as Vaccitech) is a T-cell immunotherapy company developing products to treat and prevent cancer and infectious diseases.
View company